NEWS:
LATEST STUDIES:
Search result
3 Results found
Phase III open multicentre study of a liquid formulation for growth hormone (Omnitrop®) in GHD children.
A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of LB03002, a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Daily Therapy with Genotropin in Treatment Naive Children with Growth Failure due to Insufficient Secretion of Endogenous Growth Hormone
A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of LB03002, a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Daily Therapy with Genotropin in Treatment Naive Children with Growth Failure due to Insufficient Secretion of Endogenous Growth Hormone
Studio di fase IIIB , internazionale, non comparativo, in aperto per definire il monitoraggio ottimale del IGF-1 in bambini trattati con NutropinAq utilizzando un nuovo metodo di dosaggio nel sangue capillare.
Results 3 of 3 found
1